ZA9469B - Use of idazoxan and its derivatives for the manufacture of medicaments intended for the treatment of alzheimer-type senile dementia and of pre-alzheimer's syndrome and their progression - Google Patents

Use of idazoxan and its derivatives for the manufacture of medicaments intended for the treatment of alzheimer-type senile dementia and of pre-alzheimer's syndrome and their progression

Info

Publication number
ZA9469B
ZA9469B ZA9469A ZA9469A ZA9469B ZA 9469 B ZA9469 B ZA 9469B ZA 9469 A ZA9469 A ZA 9469A ZA 9469 A ZA9469 A ZA 9469A ZA 9469 B ZA9469 B ZA 9469B
Authority
ZA
South Africa
Prior art keywords
alzheimer
idazoxan
progression
syndrome
derivatives
Prior art date
Application number
ZA9469A
Inventor
Francis Colpaert
Thierry Imbert
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of ZA9469B publication Critical patent/ZA9469B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9469A 1993-01-07 1994-01-06 Use of idazoxan and its derivatives for the manufacture of medicaments intended for the treatment of alzheimer-type senile dementia and of pre-alzheimer's syndrome and their progression ZA9469B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9300084A FR2700113B1 (en) 1993-01-07 1993-01-07 Use of Idazoxan and its derivatives for the manufacture of medicaments intended for the treatment of neurodegenerative diseases and in particular the evolution of Alzheimer's disease.

Publications (1)

Publication Number Publication Date
ZA9469B true ZA9469B (en) 1996-02-01

Family

ID=9442871

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9469A ZA9469B (en) 1993-01-07 1994-01-06 Use of idazoxan and its derivatives for the manufacture of medicaments intended for the treatment of alzheimer-type senile dementia and of pre-alzheimer's syndrome and their progression

Country Status (8)

Country Link
EP (1) EP0678024A1 (en)
JP (1) JPH08505154A (en)
AU (1) AU680463B2 (en)
CA (1) CA2153399A1 (en)
FR (1) FR2700113B1 (en)
NZ (1) NZ259531A (en)
WO (1) WO1994015603A1 (en)
ZA (1) ZA9469B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH16249A (en) * 1980-02-04 1983-08-16 Reckitt & Colmann Prod Ltd Imidazoline derivatives,its pharmaceutical composition and method of use
NZ199469A (en) * 1981-01-30 1984-03-16 Reckitt & Colmann Prod Ltd Benzodioxanyl-2-imidazoline derivatives and pharmaceutical compositions
NZ203680A (en) * 1982-04-17 1985-08-16 Reckitt & Colmann Prod Ltd Imidazolines and pharmaceutical compositions
GB2174087A (en) * 1985-04-23 1986-10-29 Glaxo Group Ltd Heterocyclic amino compounds
GB8903437D0 (en) * 1989-02-15 1989-04-05 Erba Carlo Spa Imidazolyl derivatives of 3,4-dihydro-2h-1-benzothiopyran

Also Published As

Publication number Publication date
AU5835494A (en) 1994-08-15
FR2700113A1 (en) 1994-07-08
FR2700113B1 (en) 1995-03-24
CA2153399A1 (en) 1994-07-21
EP0678024A1 (en) 1995-10-25
AU680463B2 (en) 1997-07-31
WO1994015603A1 (en) 1994-07-21
NZ259531A (en) 1997-04-24
JPH08505154A (en) 1996-06-04

Similar Documents

Publication Publication Date Title
IL110204A0 (en) Novel indolene derivatives, processes for their preparation and their use for the treatment of cns disorders
AU4069095A (en) Medicaments for the treatment of restenosis and arterial sclerosis
EP0510503A3 (en) Process for the treatment of surfaces
AU2490492A (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
KR970000398B1 (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane
AU2806692A (en) Medicament for the treatment of anxiety
AU1116895A (en) Use of theophylline for the manufacture of a medicament for the treatment of asthma
HK1001053A1 (en) Process for the manufacture of 2-alkoxymethylacrolein and its use for preparing 3-alkoxymethyl quinolines
AU4787593A (en) Heterocyclic derivatives useful in the treatment of cardiovascular diseases
HUT65134A (en) Process for the production of carbapenem-derivatives condensed with cyclohexan-ring and of pharmaceutical compositions containing it
AU5627796A (en) Medicaments for the treatment or prophylaxis of ischemia-reperfusion injury
ZA9469B (en) Use of idazoxan and its derivatives for the manufacture of medicaments intended for the treatment of alzheimer-type senile dementia and of pre-alzheimer's syndrome and their progression
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
ZA907630B (en) Process and apparatus for the"cold deep drawing"of films
AU4081393A (en) Medicaments for the treatment of anxiety
HU913369D0 (en) Process for the production of 4-hydroxistyrene salts and 4-tertier-butoxycarbonyloxy-styrene
AU8020791A (en) Method and product for the treatment of gastric disease
HU9200117D0 (en) Process for the production of 3'-fluor-pirimidine nucleozides
EP0486946A3 (en) Process for the production of metallopolysilanes and their use
HU911086D0 (en) Process for the production and use of 2-dezoxy-d-treo-pentofluoranozides and intermediers thereof
ZA921040B (en) Process for the preparation of 4-alkylsulfonyl-1-alkyl-2-chlorobenzenes and similar compounds
AU2164992A (en) Process and device for the continuous treatment of silicon
ZA955896B (en) Technetium-sulfonamide complexes their use pharmaceutical agents containing the latter as well as process for the production of the complexes and agents
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
HU9201237D0 (en) Process for the production of 2-piridylsulphonyl-carbamide-derivatives and the new intermediers used for this process